Invasive  	Invasive  	 JJ	B-NP
mycoses 	mycoses 	 NN	I-NP
:  	:  	 :	O
diagnostic  	diagnostic  	 JJ	B-NP
challenges  	challenges  	 NNS	I-NP
Despite  	Despite  	 IN	O
the  	the  	 DT	O
availability  	availability  	 NN	O
of  	of  	 IN	O
newer  	newer  	 JJR	O
antifungal  	antifungal  	 JJ	B-NP
drugs 	drugs 	 NNS	I-NP
,  	,  	 ,	O
outcomes  	outcomes  	 NNS	O
for  	for  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
invasive  	invasive  	 JJ	B-NP
fungal  	fungal  	 JJ	I-NP
infections  	infections  	 NNS	I-NP
( 	( 	 -LRB-	O
IFIs 	IFIs 	 NNP	B-NP
)  	)  	 -RRB-	O
continue  	continue  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
poor 	poor 	 JJ	O
,  	,  	 ,	O
in  	in  	 IN	O
large  	large  	 JJ	O
part  	part  	 NN	O
due  	due  	 JJ	O
to  	to  	 TO	O
delayed  	delayed  	 JJ	O
diagnosis  	diagnosis  	 NN	O
and  	and  	 CC	O
initiation  	initiation  	 NN	O
of  	of  	 IN	O
appropriate  	appropriate  	 JJ	O
antifungal  	antifungal  	 JJ	B-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
Standard  	Standard  	 JJ	B-NP
histopathologic  	histopathologic  	 JJ	I-NP
diagnostic  	diagnostic  	 JJ	I-NP
techniques  	techniques  	 NNS	I-NP
are  	are  	 VBP	O
often  	often  	 RB	O
untenable  	untenable  	 VBN	O
in  	in  	 IN	O
at-risk  	at-risk  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
culture-based  	culture-based  	 JJ	O
diagnostics  	diagnostics  	 NNS	O
typically  	typically  	 RB	O
are  	are  	 VBP	O
too  	too  	 RB	O
insensitive  	insensitive  	 JJ	O
or  	or  	 CC	O
nonspecific 	nonspecific 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
provide  	provide  	 VB	O
results  	results  	 NNS	O
after  	after  	 IN	O
too  	too  	 RB	O
long  	long  	 RB	O
a  	a  	 DT	O
delay  	delay  	 NN	O
for  	for  	 IN	O
optimal  	optimal  	 JJ	B-NP
IFI  	IFI  	 NNP	I-NP
management 	management 	 NN	I-NP
.  	.  	 .	O
Newer  	Newer  	 JJR	B-NP
surrogate  	surrogate  	 JJ	I-NP
markers  	markers  	 NN	I-NP
of  	of  	 IN	O
IFIs  	IFIs  	 JJ	O
with  	with  	 IN	O
improved  	improved  	 JJ	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 NNS	O
are  	are  	 VBP	O
needed  	needed  	 VBN	O
to  	to  	 TO	O
enable  	enable  	 VB	O
earlier  	earlier  	 JJR	O
diagnosis  	diagnosis  	 NN	O
and 	and 	 CC	O
,  	,  	 ,	O
ideally 	ideally 	 NN	O
,  	,  	 ,	O
to  	to  	 TO	O
provide  	provide  	 VB	O
prognostic  	prognostic  	 JJ	B-NP
information  	information  	 NN	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
permit  	permit  	 VB	O
therapeutic  	therapeutic  	 JJ	B-NP
monitoring 	monitoring 	 NN	I-NP
.  	.  	 .	O
Surrogate  	Surrogate  	 JJ	B-NP
assays  	assays  	 NN	I-NP
should  	should  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
accessible  	accessible  	 JJ	O
and  	and  	 CC	O
easy  	easy  	 JJ	O
to  	to  	 TO	O
implement  	implement  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
hospital 	hospital 	 NN	O
.  	.  	 .	O
Several  	Several  	 JJ	O
nonculture-based  	nonculture-based  	 JJ	B-NP
assays  	assays  	 NN	I-NP
of  	of  	 IN	O
newer  	newer  	 JJR	O
surrogates  	surrogates  	 NNS	O
are  	are  	 VBP	O
making  	making  	 VBG	O
their  	their  	 PRP$	O
way  	way  	 NN	O
into  	into  	 IN	O
the  	the  	 DT	O
medical  	medical  	 JJ	B-NP
setting  	setting  	 NN	I-NP
or  	or  	 CC	O
are  	are  	 VBP	O
currently  	currently  	 RB	O
under  	under  	 IN	O
investigation 	investigation 	 NN	B-NP
.  	.  	 .	O
These  	These  	 DT	O
new  	new  	 JJ	O
or  	or  	 CC	O
up-and-coming  	up-and-coming  	 JJ	O
surrogates  	surrogates  	 NNS	O
include  	include  	 VBP	O
antigens 	antigens 	 RB	O
/ 	/ 	 CD	O
antibodies  	antibodies  	 NNS	O
( 	( 	 -LRB-	O
mannan  	mannan  	 NN	B-NP
and  	and  	 CC	O
antimannan  	antimannan  	 JJ	B-NP
antibodies 	antibodies 	 NNS	I-NP
)  	)  	 -RRB-	O
or  	or  	 CC	O
fungal  	fungal  	 JJ	B-NP
metabolites  	metabolites  	 NNS	I-NP
( 	( 	 -LRB-	O
d-arabinitol 	d-arabinitol 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
detection  	detection  	 NN	O
of  	of  	 IN	O
invasive  	invasive  	 JJ	B-NP
candidiasis 	candidiasis 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
Aspergillus  	Aspergillus  	 JJ	B-NP
cell  	cell  	 NN	I-NP
wall  	wall  	 NN	I-NP
component  	component  	 NN	I-NP
galactomannan  	galactomannan  	 VBZ	O
used  	used  	 VBN	O
to  	to  	 TO	O
detect  	detect  	 VB	O
invasive  	invasive  	 JJ	B-NP
aspergillosis 	aspergillosis 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
the  	the  	 DT	O
fungal  	fungal  	 JJ	B-NP
cell  	cell  	 NN	I-NP
wall  	wall  	 NN	I-NP
component  	component  	 NN	I-NP
and  	and  	 CC	O
panfungal  	panfungal  	 JJ	B-NP
marker  	marker  	 JJ	I-NP
β-glucan 	β-glucan 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
progress  	progress  	 NN	O
continues  	continues  	 VBZ	O
with  	with  	 IN	O
use  	use  	 NN	O
of  	of  	 IN	O
polymerase  	polymerase  	 JJ	B-NP
chain  	chain  	 NN	I-NP
reaction-  	reaction-  	 NN	I-NP
or  	or  	 CC	O
other  	other  	 JJ	O
nucleic  	nucleic  	 JJ	B-NP
acid-  	acid-  	 JJ	I-NP
or  	or  	 CC	O
molecular-based  	molecular-based  	 JJ	O
assays  	assays  	 NN	O
for  	for  	 IN	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
either  	either  	 DT	O
specific  	specific  	 JJ	O
or  	or  	 CC	O
generic  	generic  	 JJ	B-NP
IFIs 	IFIs 	 NN	I-NP
,  	,  	 ,	O
although  	although  	 IN	O
the  	the  	 DT	O
various  	various  	 JJ	O
methods  	methods  	 NNS	O
must  	must  	 MD	O
be  	be  	 VB	O
better  	better  	 RBR	O
standardized  	standardized  	 JJ	O
before  	before  	 IN	O
any  	any  	 DT	O
of  	of  	 IN	O
these  	these  	 DT	O
approaches  	approaches  	 NNS	O
can  	can  	 MD	O
be  	be  	 VB	O
more  	more  	 RBR	O
fully  	fully  	 RB	O
implemented  	implemented  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
medical  	medical  	 JJ	B-NP
setting 	setting 	 NN	I-NP
.  	.  	 .	O
Investigators  	Investigators  	 NNS	B-NP
are  	are  	 VBP	O
also  	also  	 RB	O
beginning  	beginning  	 VBG	O
to  	to  	 TO	O
explore  	explore  	 VB	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
of  	of  	 IN	O
combining  	combining  	 VBG	O
newer  	newer  	 JJR	O
surrogate  	surrogate  	 JJ	O
markers  	markers  	 NN	O
with  	with  	 IN	O
each  	each  	 DT	O
other  	other  	 JJ	O
or  	or  	 CC	O
with  	with  	 IN	O
more  	more  	 RBR	O
standard  	standard  	 JJ	O
diagnostic  	diagnostic  	 JJ	B-NP
approaches  	approaches  	 NNS	I-NP
to  	to  	 TO	O
improve  	improve  	 VB	O
sensitivity 	sensitivity 	 NN	O
,  	,  	 ,	O
specificity 	specificity 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
capacity  	capacity  	 NN	O
for  	for  	 IN	O
earlier  	earlier  	 JJR	O
diagnosis 	diagnosis 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
a  	a  	 DT	O
time  	time  	 NN	O
when  	when  	 WRB	O
fungal  	fungal  	 JJ	B-NP
burden  	burden  	 NN	I-NP
is  	is  	 VBZ	O
still  	still  	 RB	O
relatively  	relatively  	 RB	O
low  	low  	 JJ	O
and  	and  	 CC	O
more  	more  	 RBR	O
responsive  	responsive  	 JJ	O
to  	to  	 TO	O
antifungal  	antifungal  	 VB	O
therapy 	therapy 	 NN	O
.  	.  	 .	O
